MedPath

App-based Intervention for Treating Insomnia Among Patients With Epilepsy

Not Applicable
Completed
Conditions
Insomnia
Epilepsy
Interventions
Behavioral: Sleep Health
Other: Patient education
Registration Number
NCT03683381
Lead Sponsor
Qazvin University Of Medical Sciences
Brief Summary

Sleep can affect frequency and occurrence of interictal spikes and occurrence, timing, and threshold of seizure. Epilepsy can worsen sleep architecture and severity of sleep disorders. Thus, a vicious cycle is set. Certain epilepsy syndromes are so intertwined with sleep that they are considered sleep-related epilepsies. Poor sleep in epilepsy is multifactorial and is worsened by poorly controlled seizures. App-delivered intervention has shown promise as a method to overcome health issues; however, the long-term effectiveness has not been proven in epileptic patients with chronic insomnia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
320
Inclusion Criteria
  • Are at least 18 years of age
  • diagnosis of epilepsy according to the International League Against Epilepsy criteria
  • Self-report "moderate or severe" insomnia as indicated by a score of 15 or higher on the Insomnia Severity Index
  • Can speak, understand, and write in Persian
  • No surgery planned in the next 6 months
  • Have access to an Android smartphone or a desktop computer with Internet access
  • absence of major cognitive impairment or active psychiatric disorders
Exclusion Criteria
  • presence of a rapidly progressing neurological or medical disorder
  • a diagnosis of mental retardation
  • use of drugs or alcohol
  • Untreated sleep apnea
  • Current pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
interventionSleep HealthPatients in the intervention group will receive a 6-week app-based intervention to treat insomnia
patient educationPatient educationParticipants in the patient education group will receive weekly information on insomnia symptoms
Primary Outcome Measures
NameTimeMethod
objective sleep measurechanges in objective sleep baseline , 1 month and 6 months follow-up

Sleep data is measured by Actigraphy (total minutes asleep, sleep effectiveness, sleep latency, awakenings). A wrist actigraph will be worn by the patients for 7 consecutive days.

sleep hygiene behaviorchanges in sleep hygiene behavior baseline , 1 month, 3 months and 6 months follow-up

Sleep hygiene behaviour will use three items to measure how many days the participants had good sleep hygiene.

behaviour.

Insomnia symptomschanges in ISI baseline , 1 month, 3 months and 6 months follow-up

Isomnia symptom severity will be assessed using the Insomnia Severity Index

Secondary Outcome Measures
NameTimeMethod
Anxiety and Depressionchanges from baseline , changes from baseline , 1 month and 6 Months follow-up

Zigmond and Snaith developed the 14-item HADS to measure the anxiety (7 items) and depression (7 items) of patients with both somatic and mental problems. The response descriptors of all items are Yes, definitely (score 3); Yes, sometimes (score 2); No, not much (score 1); No, not at all (score 0); except for items 7 and 10, which are scored reversely. A higher score represents higher levels of anxiety and depression: a domain score of 11 or greater indicates anxiety or depression; 8-10 indicates borderline case; 7 or lower indicates no signs of anxiety or depression. The two-factor framework of the HADS has been supported in epileptic patients.

Psychological predictors of sleep hygiene behavior (attitude, habit, self monitoring, self control, perceived behavior controlchanges from baseline , changes from baseline , 1 month and 6 Months follow-up

psychological predictors of sleep hygiene behavior will be assessed using a using a self-reported measure. All items are rated on a Likert-type scale, ranging from 1 to 5.

Health related Quality of lifechanges from baseline, changes from baseline , 1 month and 6 Months follow-up

quality of Life in Epilepsy (QOLIE-31) will be used to assess quality of life

Trial Locations

Locations (4)

Firoozgar Hospital

🇮🇷

Tehran, Iran, Islamic Republic of

Booali Sina Hospital

🇮🇷

Qazvin, Iran, Islamic Republic of

Shahid Rajaie Hospital

🇮🇷

Qazvin, Iran, Islamic Republic of

Mollasadra Neurology Clinic

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath